Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Ocrelizumab may cause pancreatitis in some patients.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Adding a second method to PROTACs could improve cancer treatment.

Co-trimoxazole may help treat autoimmune diseases.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Pulsed electric field treatment may help the immune system fight liver tumors.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Apremilast may help treat hair loss in alopecia areata.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.